Public drug program spending in Canada by top drug classes 2017

Top 10 drug classes by share of total public drug program spending in Canada in 2017*

by Statista Research Department, last edited Nov 26, 2018
Public drug program spending in Canada by top drug classes 2017 This statistic shows the top 10 drug classes in Canada based on share of total public drug program expenditures in 2017. In that year, 2.8 percent of total drug program spending was dedicated to HMG-CoA reductase inhibitors (statins) which are often used for treating high cholesterol.
Show more

Top 10 drug classes by share of total public drug program spending in Canada in 2017*

Loading statistic...
Share of total public drug program spending
Tumour necrosis factor alpha inhibitors (anti-TNF drugs)8.2%
Antivirals for treatment of hepatitis C infections**5%
Antineovascularization agents***4.6%
HMG-CoA reductase inhibitors (statins)2.8%
Other antipsychotics2.4%
Adrenergics in combination with corticosteroids or other drugs, excluding anticholinergics2.3%
Oral protein kinase inhibitors2.3%
Selective immunosuppressants2.2%
Proton pump inhibitors (PPIs)2.1%
Direct factor Xa inhibitors2%
Share of total public drug program spending
Tumour necrosis factor alpha inhibitors (anti-TNF drugs)8.2%
Antivirals for treatment of hepatitis C infections**5%
Antineovascularization agents***4.6%
HMG-CoA reductase inhibitors (statins)2.8%
Other antipsychotics2.4%
Adrenergics in combination with corticosteroids or other drugs, excluding anticholinergics2.3%
Oral protein kinase inhibitors2.3%
Selective immunosuppressants2.2%
Proton pump inhibitors (PPIs)2.1%
Direct factor Xa inhibitors2%
Download Settings Share
Download started
Please be patient - this may take a moment
by Statista Research Department, last edited Nov 26, 2018
This statistic shows the top 10 drug classes in Canada based on share of total public drug program expenditures in 2017. In that year, 2.8 percent of total drug program spending was dedicated to HMG-CoA reductase inhibitors (statins) which are often used for treating high cholesterol.
Show more
Statista Accounts: Access All Statistics. Starting from $588 / Year
Basic Account
Get to know the platform

You only have access to basic statistics.

Premium Account
Your perfect start with Statista
  • Instant access to 1m statistics
  • Download in XLS, PDF & PNG format
  • Detailed references

$49 / Month *

Corporate Account
Full access

Corporate solution including all features.

* All products require an annual contract.
   Prices do not include sales tax.
Leading companies trust Statista:
paypalgoogleadobepgsamsungtelekom
Statista is a great source of knowledge, and pretty helpful to manage the daily work.
Christof Baron

Christof Baron
CEO, MindShare Germany

Statistics on "Canadian pharmaceutical industry"
  • Global positioning
The most important statistics
  • Key figures
  • Regional comparison
  • Generics
  • Products and prices
Discover Statista
Need help with using Statista for your research? Tutorials and first steps
Further Content: Statistics, Studies, and Topic Pages
Learn more about how Statista can support your business.
Do you have any questions about our business solutions?

We provide you with detailed information about our Corporate Account.